Índice

• • ·FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains

    Página :i

    Sandip Basu, Rakesh Kumar, Abass Alavi

    
• • ·Copyright

    Página :ii

    
• • ·Contributors

    Página :iii

    Esquema Esquema
• • ·Contents

    Página :vii

    Esquema Esquema
• • ·Forthcoming Issues

    Página :xi

    Esquema Esquema
• • ·CME Accreditation Page

    Página :xiii

    
• • ·Fluorodeoxyglucose versus Non-Fluorodeoxyglucose PET-Computed Tomography in Less-Explored Domains: An Appraisal

    Página :xv

    Sandip Basu, Rakesh Kumar, Abass Alavi

     
• • ·Facts and Fictions About [¹⁸F]FDG versus Other Tracers in Managing Patients with Brain Tumors : It Is Time to Rectify the Ongoing Misconceptions

    Página :327-342

    Nadia Withofs, Rakesh Kumar, Abass Alavi, Roland Hustinx

    Resumen Resumen Esquema Esquema  
• • ·An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non–Thyroid Endocrine Neoplasms

    Página :343-367

    Aadil Adnan, Shobhana Raju, Rakesh Kumar, Sandip Basu

    Resumen Resumen Esquema Esquema  
• • ·18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies

    Página :369-388

    Gopinath Gnanasegaran, Kanhaiyalal Agrawal, Simon Wan

    Resumen Resumen Esquema Esquema  
• • ·Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer

    Página :389-397

    Hossein Jadvar, Patrick M. Colletti

    Resumen Resumen Esquema Esquema  
• • ·Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer : An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers

    Página :399-413

    Divya Yadav, Rakesh Kumar, Ankita Phulia, Sandip Basu, Abass Alavi

    Resumen Resumen Esquema Esquema  
• • ·¹⁸F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma

    Página :415-430

    Angel Hemrom, Avinash Tupalli, Abass Alavi, Rakesh Kumar

    Resumen Resumen Esquema Esquema  
• • ·Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors

    Página :431-451

    Austin J. Borja, Jitender Saini, William Y. Raynor, Cyrus Ayubcha, Thomas J. Werner, Abass Alavi, Mona-Elisabeth Revheim, Chandana Nagaraj

    Resumen Resumen Esquema Esquema  
• • ·Fibroblast Activation Protein Inhibitor Theranostics

    Página :453-464

    Shobhana Raju, Jaya Shukla, Rakesh Kumar

    Resumen Resumen Esquema Esquema  
• • ·PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders

    Página :465-478

    Rahul V. Parghane, Sandip Basu

    Resumen Resumen Esquema Esquema  
• • ·Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings

    Página :479-494

    Andrew B. Newberg, Roger Coble, Mohsen Khosravi, Abass Alavi

    Resumen Resumen Esquema Esquema  
• • ·Nonmalignant Thoracic Disorders : An Appraisal of Fluorodeoxyglucose and Non-fluorodeoxyglucose PET/Computed Tomography Applications

    Página :495-515

    Vandana Kumar Dhingra, Dikhra Khan, Rakesh Kumar, Sandip Basu

    Resumen Resumen Esquema Esquema  
• • ·Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot : A Comparative Perspective with Other Functional Imaging Modalities

    Página :517-531

    Swati Sodagar Rachh, Sandip Basu, Abass Alavi

    Resumen Resumen Esquema Esquema  
• • ·Utility of PET/Computed Tomography in Infection and Inflammation Imaging

    Página :533-542

    Jasim Jaleel, Sambit Sagar, Rakesh Kumar

    Resumen Resumen Esquema Esquema  
• • ·Role of Fluorodeoxyglucose-PET in Interventional Radiology

    Página :543-553

    Alireza Zandifar, Joey Saucedo, Arastoo Vossough, Abass Alavi, Stephen J. Hunt

    Resumen Resumen Esquema Esquema